{"transactions":[{"id":804255,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:02.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":570719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the option vest on October 13, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":570719,"derivative":{"exercise_price":4.62,"expiration_date":"2035-10-14","underlying":"Common Stock","underlying_shares":570719},"source":{"system":"sec-edgar","filing":"0001786386-26-000006","document":"form4-04212026_120457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1786386/000178638626000006/form4-04212026_120457.xml","form_type":"4"}},{"id":804254,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:02.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":570719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the option vest on October 13, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.62,"expiration_date":"2035-10-14","underlying":"Class B Common Stock","underlying_shares":570719},"source":{"system":"sec-edgar","filing":"0001786386-26-000006","document":"form4-04212026_120457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1786386/000178638626000006/form4-04212026_120457.xml","form_type":"4"}},{"id":804253,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T00:33:02.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":163358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":163358,"derivative":{"exercise_price":17,"expiration_date":"2036-04-15","underlying":"Common Stock","underlying_shares":163358},"source":{"system":"sec-edgar","filing":"0001786386-26-000006","document":"form4-04212026_120457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786386/000178638626000006/form4-04212026_120457.xml","form_type":"4"}},{"id":804252,"issuer":{"id":1791,"kind":"organization","name":"Alamar Biosciences, Inc.","symbol":"ALMR"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-21T00:33:02.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":37220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":37220,"source":{"system":"sec-edgar","filing":"0001786386-26-000006","document":"form4-04212026_120457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786386/000178638626000006/form4-04212026_120457.xml","form_type":"4"}},{"id":1422932,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"other":true,"other_text":"Former Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-26T21:03:29.000Z","date":"2024-08-22","kind":"sale","planned":false,"acquired":false,"shares":2961,"price":22.5297,"value":66710.4417,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":143242,"source":{"system":"sec-edgar","filing":"0001610717-24-000453","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000453/form4.xml","form_type":"4"}},{"id":1503173,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-23T23:54:01.000Z","date":"2024-05-22","kind":"sale","planned":false,"acquired":false,"shares":2936,"price":24.3036,"value":71355.3696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 587 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 14, 2024."}],"balance_after":146203,"source":{"system":"sec-edgar","filing":"0001610717-24-000259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000259/form4.xml","form_type":"4"}},{"id":1561631,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-25T21:15:43.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":53312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2024, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":148552,"source":{"system":"sec-edgar","filing":"0001610717-24-000184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000184/form4.xml","form_type":"4"}},{"id":1618519,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-26T21:12:10.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":1865,"price":46.3443,"value":86432.1195,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":95240,"source":{"system":"sec-edgar","filing":"0001610717-24-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071724000090/form4.xml","form_type":"4"}},{"id":1729316,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-27T23:15:58.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":1679,"price":43.3367,"value":72762.3193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":97105,"source":{"system":"sec-edgar","filing":"0001610717-23-000365","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000365/form4.xml","form_type":"4"}},{"id":1797356,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-24T21:09:37.000Z","date":"2023-08-22","kind":"sale","planned":false,"acquired":false,"shares":1678,"price":45.7811,"value":76820.6858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":98784,"source":{"system":"sec-edgar","filing":"0001610717-23-000237","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000237/form4.xml","form_type":"4"}},{"id":1877606,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-25T21:48:38.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":565,"price":55.0637,"value":31110.9905,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":100462,"source":{"system":"sec-edgar","filing":"0001610717-23-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000064/form4.xml","form_type":"4"}},{"id":1877605,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-25T21:48:38.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":441,"price":55.0641,"value":24283.2681,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":101027,"source":{"system":"sec-edgar","filing":"0001610717-23-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000064/form4.xml","form_type":"4"}},{"id":1877604,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-25T21:48:38.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":465,"price":55.0621,"value":25603.8765,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":101468,"source":{"system":"sec-edgar","filing":"0001610717-23-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000064/form4.xml","form_type":"4"}},{"id":1877603,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-25T21:48:38.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":194,"price":55.0695,"value":10683.483,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 617 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 12, 2023."}],"balance_after":101933,"source":{"system":"sec-edgar","filing":"0001610717-23-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000064/form4.xml","form_type":"4"}},{"id":1939924,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Performance based Restricted Stock Units","published_at":"2023-03-23T22:25:49.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":12996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest\nupon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through\neach such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest\nupon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through\neach such date."}],"balance_after":12996,"derivative":{"expiration_date":"2028-04-01","underlying":"Class A Common Stock","underlying_shares":12996},"source":{"system":"sec-edgar","filing":"0001140361-23-013504","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013504/form4.xml","form_type":"4"}},{"id":1939923,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-23T22:25:49.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":25991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a\nservice provider through each such date."}],"balance_after":25991,"derivative":{"exercise_price":50.1,"expiration_date":"2033-03-21","underlying":"Class A Common Stock","underlying_shares":25991},"source":{"system":"sec-edgar","filing":"0001140361-23-013504","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013504/form4.xml","form_type":"4"}},{"id":1939922,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-23T22:25:49.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":25991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest\non each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":101510,"source":{"system":"sec-edgar","filing":"0001140361-23-013504","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013504/form4.xml","form_type":"4"}},{"id":1992228,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T22:53:16.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":1245,"price":47.7533,"value":59452.8585,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":75519,"source":{"system":"sec-edgar","filing":"0001567619-23-003782","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761923003782/doc1.xml","form_type":"4"}},{"id":2104817,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-23T22:02:02.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":288,"price":34.0665,"value":9811.152,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":76764,"source":{"system":"sec-edgar","filing":"0001567619-22-020869","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922020869/doc1.xml","form_type":"4"}},{"id":2104816,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-23T22:02:02.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":652,"price":34.0679,"value":22212.2708,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":77052,"source":{"system":"sec-edgar","filing":"0001567619-22-020869","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922020869/doc1.xml","form_type":"4"}},{"id":2104815,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-23T22:02:02.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":686,"price":34.0651,"value":23368.6586,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1 share acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2022."}],"balance_after":77704,"source":{"system":"sec-edgar","filing":"0001567619-22-020869","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922020869/doc1.xml","form_type":"4"}},{"id":2156881,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2022-09-16T21:34:07.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":40593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":40593,"derivative":{"expiration_date":"2026-09-14","underlying":"Class A Common Stock","underlying_shares":40593},"source":{"system":"sec-edgar","filing":"0001567619-22-017565","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922017565/doc1.xml","form_type":"4"}},{"id":2156880,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-16T21:34:07.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":40593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2022, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":40593,"derivative":{"exercise_price":33.67,"expiration_date":"2032-09-14","underlying":"Class A Common Stock","underlying_shares":40593},"source":{"system":"sec-edgar","filing":"0001567619-22-017565","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922017565/doc1.xml","form_type":"4"}},{"id":2156879,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-16T21:34:07.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":20297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from August 21, 2022, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":78389,"source":{"system":"sec-edgar","filing":"0001567619-22-017565","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922017565/doc1.xml","form_type":"4"}},{"id":2173634,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-25T20:59:56.000Z","date":"2022-08-23","kind":"sale","acquired":false,"shares":987,"price":35.1913,"value":34733.8131,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":58092,"source":{"system":"sec-edgar","filing":"0001567619-22-016677","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922016677/doc1.xml","form_type":"4"}},{"id":2256360,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-25T22:32:00.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":967,"price":48.7641,"value":47154.8847,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":59079,"source":{"system":"sec-edgar","filing":"0001567619-22-011713","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922011713/doc1.xml","form_type":"4"}},{"id":2267269,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-17T21:28:13.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":158,"price":40.4855,"value":6396.709,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase was made under the Issuer's 2019 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) under Rule 16b-3(c)."}],"balance_after":60046,"source":{"system":"sec-edgar","filing":"0001567619-22-011123","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922011123/doc1.xml","form_type":"4"}},{"id":2318544,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-24T21:14:39.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":53392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":53392,"derivative":{"exercise_price":69.56,"expiration_date":"2032-03-22","underlying":"Class A Common Stock","underlying_shares":53392},"source":{"system":"sec-edgar","filing":"0001567619-22-007440","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922007440/doc1.xml","form_type":"4"}},{"id":2318543,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-24T21:14:39.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":21357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall\nvest on May 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":59888,"source":{"system":"sec-edgar","filing":"0001567619-22-007440","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922007440/doc1.xml","form_type":"4"}},{"id":2373888,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-25T00:38:29.000Z","date":"2022-02-22","kind":"sale","acquired":false,"shares":288,"price":78.5994,"value":22636.6272,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":38531,"source":{"system":"sec-edgar","filing":"0001567619-22-005520","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922005520/doc1.xml","form_type":"4"}},{"id":2442551,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T22:16:39.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, originally for 600,000 shares, of which 249,841 shares have been exercised, vested as to 1/4th of the shares on October 8, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":350159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-22-000622","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922000622/doc1.xml","form_type":"4"}},{"id":2442550,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-05T22:16:39.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":500,"price":149.178,"value":74589.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $148.66 to $149.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":38819,"source":{"system":"sec-edgar","filing":"0001567619-22-000622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922000622/doc1.xml","form_type":"4"}},{"id":2442549,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-05T22:16:39.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":500,"price":148.044,"value":74022.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $147.58 to $148.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39319,"source":{"system":"sec-edgar","filing":"0001567619-22-000622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922000622/doc1.xml","form_type":"4"}},{"id":2442548,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-05T22:16:39.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1334,"price":146.9178,"value":195988.3452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $146.54 to $147.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39819,"source":{"system":"sec-edgar","filing":"0001567619-22-000622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922000622/doc1.xml","form_type":"4"}},{"id":2442547,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-05T22:16:39.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":4083,"price":145.9556,"value":595936.7148,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $145.54 to $146.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":41153,"source":{"system":"sec-edgar","filing":"0001567619-22-000622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922000622/doc1.xml","form_type":"4"}},{"id":2442546,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-05T22:16:39.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":3583,"price":145.1619,"value":520115.0877,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $144.54 to $145.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45236,"source":{"system":"sec-edgar","filing":"0001567619-22-000622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922000622/doc1.xml","form_type":"4"}},{"id":2442545,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-05T22:16:39.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":48819,"source":{"system":"sec-edgar","filing":"0001567619-22-000622","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922000622/doc1.xml","form_type":"4"}},{"id":2484798,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option, originally for 600,000 shares, of which 239,841 shares have been exercised, vested as to 1/4th of the shares on October 8, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":360159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484797,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":100,"price":155.55,"value":15555.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":38819,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484796,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":200,"price":153.8576,"value":30771.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $153.58 to $154.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":38919,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484795,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":300,"price":151.7967,"value":45539.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $151.50 to $152.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39119,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484794,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":300,"price":151.3147,"value":45394.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $151.26 to $151.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39419,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484793,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":500,"price":150.714,"value":75357.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $150.16 to $150.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39719,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484792,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":600,"price":149.405,"value":89643.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $149.14 to $150.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":40219,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484791,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":1302,"price":148.48,"value":193320.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $148.13 to $149.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":40819,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484790,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2700,"price":147.6158,"value":398562.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $147.06 to $148.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":42121,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484789,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":1536,"price":146.4937,"value":225014.3232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $146.03 to $147.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":44821,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484788,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2462,"price":145.5415,"value":358323.173,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $145.01 to $145.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":46357,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2484787,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T22:55:33.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":48819,"source":{"system":"sec-edgar","filing":"0001567619-21-021618","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021618/doc1.xml","form_type":"4"}},{"id":2494680,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-25T02:10:53.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":281,"price":148.3811,"value":41695.0891,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":38819,"source":{"system":"sec-edgar","filing":"0001567619-21-021189","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921021189/doc1.xml","form_type":"4"}},{"id":2525559,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T23:14:27.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, originally for 600,000 shares, of which 229,841 shares have been exercised, vested as to 1/4th of the shares on October 8, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":370159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-019299","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921019299/doc1.xml","form_type":"4"}},{"id":2525558,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T23:14:27.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":200,"price":164.962,"value":32992.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $164.81 to $165.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39100,"source":{"system":"sec-edgar","filing":"0001567619-21-019299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921019299/doc1.xml","form_type":"4"}},{"id":2525557,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T23:14:27.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":4333,"price":164.0542,"value":710846.8486,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $163.65 to $164.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39300,"source":{"system":"sec-edgar","filing":"0001567619-21-019299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921019299/doc1.xml","form_type":"4"}},{"id":2525556,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T23:14:27.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":4667,"price":163.3414,"value":762314.3138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $162.65 to $163.645. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43633,"source":{"system":"sec-edgar","filing":"0001567619-21-019299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921019299/doc1.xml","form_type":"4"}},{"id":2525555,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T23:14:27.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":500,"price":162.1577,"value":81078.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $161.52 to $162.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":48300,"source":{"system":"sec-edgar","filing":"0001567619-21-019299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921019299/doc1.xml","form_type":"4"}},{"id":2525554,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T23:14:27.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":300,"price":160.475,"value":48142.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $160.03 to $160.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":48800,"source":{"system":"sec-edgar","filing":"0001567619-21-019299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921019299/doc1.xml","form_type":"4"}},{"id":2525553,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T23:14:27.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":49100,"source":{"system":"sec-edgar","filing":"0001567619-21-019299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921019299/doc1.xml","form_type":"4"}},{"id":2547772,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-05T20:55:00.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, originally for 600,000 shares, of which 219,841 shares have been exercised, vested as to 1/4th of the shares on October 8, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":380159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-21-017949","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921017949/doc1.xml","form_type":"4"}},{"id":2547771,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-05T20:55:00.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1200,"price":144.5708,"value":173484.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $144.325 to $145.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39100,"source":{"system":"sec-edgar","filing":"0001567619-21-017949","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921017949/doc1.xml","form_type":"4"}},{"id":2547770,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-05T20:55:00.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":5666,"price":143.7919,"value":814724.9054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $143.30 to $144.275. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":40300,"source":{"system":"sec-edgar","filing":"0001567619-21-017949","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921017949/doc1.xml","form_type":"4"}},{"id":2547769,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-05T20:55:00.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":2500,"price":142.8031,"value":357007.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $142.25 to $143.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45966,"source":{"system":"sec-edgar","filing":"0001567619-21-017949","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921017949/doc1.xml","form_type":"4"}},{"id":2547768,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-05T20:55:00.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":634,"price":141.961,"value":90003.274,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $141.25 to $142.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":48466,"source":{"system":"sec-edgar","filing":"0001567619-21-017949","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921017949/doc1.xml","form_type":"4"}},{"id":2547767,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-05T20:55:00.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":49100,"source":{"system":"sec-edgar","filing":"0001567619-21-017949","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761921017949/doc1.xml","form_type":"4"}},{"id":2578279,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-03T23:54:01.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, originally for 600,000 shares, of which 209,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":390159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-054900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121054900/doc4.xml","form_type":"4"}},{"id":2578278,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-03T23:54:01.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":1540,"price":178.8041,"value":275358.314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $178.41 to $179.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39100,"source":{"system":"sec-edgar","filing":"0001209191-21-054900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121054900/doc4.xml","form_type":"4"}},{"id":2578277,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-03T23:54:01.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":4747,"price":177.8722,"value":844359.3334,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $177.41 to $178.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":40640,"source":{"system":"sec-edgar","filing":"0001209191-21-054900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121054900/doc4.xml","form_type":"4"}},{"id":2578276,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-03T23:54:01.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":2200,"price":176.9982,"value":389396.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $176.39 to $177.355. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45387,"source":{"system":"sec-edgar","filing":"0001209191-21-054900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121054900/doc4.xml","form_type":"4"}},{"id":2578275,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-03T23:54:01.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":1139,"price":175.9542,"value":200411.8338,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $175.34 to $176.285. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":47587,"source":{"system":"sec-edgar","filing":"0001209191-21-054900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121054900/doc4.xml","form_type":"4"}},{"id":2578274,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-03T23:54:01.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":374,"price":174.87,"value":65401.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $174.20 to $175.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":48726,"source":{"system":"sec-edgar","filing":"0001209191-21-054900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121054900/doc4.xml","form_type":"4"}},{"id":2578273,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-03T23:54:01.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":49100,"source":{"system":"sec-edgar","filing":"0001209191-21-054900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121054900/doc4.xml","form_type":"4"}},{"id":2590438,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-26T00:37:42.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":270,"price":161.8475,"value":43698.825,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":39100,"source":{"system":"sec-edgar","filing":"0001209191-21-053392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121053392/doc4.xml","form_type":"4"}},{"id":2614117,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option, originally for 600,000 shares, of which 199,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":400159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614116,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":300,"price":184.5233,"value":55356.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $184.19 to $184.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39370,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614115,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":500,"price":183.3,"value":91650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $182.93 to $183.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39670,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614114,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":700,"price":182.1629,"value":127514.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $181.93 to $182.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":40170,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614113,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":2302,"price":181.3101,"value":417375.8502,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $180.89 to $181.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":40870,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614112,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":2298,"price":180.289,"value":414304.122,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $179.89 to $180.865. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43172,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614111,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":2202,"price":179.2825,"value":394780.065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $178.865 to $179.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45470,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614110,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":1698,"price":178.3509,"value":302839.8282,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $177.80 to $178.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":47672,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2614109,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T20:46:48.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":49370,"source":{"system":"sec-edgar","filing":"0001209191-21-049650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121049650/doc4.xml","form_type":"4"}},{"id":2640352,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option, originally for 600,000 shares, of which 189,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":410159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640351,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":100,"price":195.82,"value":19582.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":39370,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640350,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":700,"price":194.8054,"value":136363.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $194.40 to $195.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39470,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640349,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":1400,"price":193.7629,"value":271268.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $193.38 to $194.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":40170,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640348,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":800,"price":192.9473,"value":154357.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $192.32 to $193.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":41570,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640347,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":1500,"price":191.7347,"value":287602.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $191.32 to $192.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":42370,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640346,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":2800,"price":190.6638,"value":533858.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $190.25 to $191.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43870,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640345,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":2700,"price":189.8522,"value":512600.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $189.24 to $190.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":46670,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2640344,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-06T20:29:40.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 359 shares previously acquired under the Issuer's 2019 Employee Stock Purchase Plan."}],"balance_after":49370,"source":{"system":"sec-edgar","filing":"0001209191-21-045475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121045475/doc4.xml","form_type":"4"}},{"id":2682217,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option, originally for 600,000 shares, of which 179,841 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":420159,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682216,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":300,"price":180.0233,"value":54006.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $179.97 to $180.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39011,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682215,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":200,"price":179.2075,"value":35841.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $178.92 to $179.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39311,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682214,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":300,"price":178.0667,"value":53420.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $177.65 to $178.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39511,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682213,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2906,"price":175.7695,"value":510786.167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $175.42 to $176.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39811,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682212,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":1994,"price":174.9286,"value":348807.6284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $174.38 to $175.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":42717,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682211,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":1000,"price":173.944,"value":173944.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $173.36 to $174.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":44711,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682210,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":800,"price":172.8482,"value":138278.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $172.25 to $173.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45711,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682209,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2500,"price":171.5938,"value":428984.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $171.12 to $172.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":46511,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2682208,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-03T22:51:14.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":10000,"price":5.04,"value":50400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise and the sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":49011,"source":{"system":"sec-edgar","filing":"0001209191-21-037902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121037902/doc4.xml","form_type":"4"}},{"id":2694567,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":51897,"kind":"person","name":"McAnear Justin J.","position":1,"cik":"0001786386","reported_name":"McAnear Justin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-27T00:26:47.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":22338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":22338,"derivative":{"exercise_price":177.76,"expiration_date":"2031-03-19","underlying":"Class A Common Stock","underlying_shares":22338},"source":{"system":"sec-edgar","filing":"0001209191-21-036102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000120919121036102/doc4.xml","form_type":"4"}}],"next_cursor":"2021-05-27T00:26:47.000000Z,2694567"}